View ValuationGuizhou RedStar DevelopingLtd 将来の成長Future 基準チェック /06現在、 Guizhou RedStar DevelopingLtdの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長29.7%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • Apr 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 25% per year over the past 5 years. Minor Risk Large one-off items impacting financial results.Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.08 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.08 (down from CN¥0.09 in 1Q 2025). Revenue: CN¥472.9m (down 11% from 1Q 2025). Net income: CN¥28.6m (down 2.3% from 1Q 2025). Profit margin: 6.1% (up from 5.5% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.お知らせ • Apr 25Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 18, 2026Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Anshun, Guizhou Chinaお知らせ • Mar 30Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2026 Results on Apr 25, 2026Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2026 results on Apr 25, 2026Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥26.81, the stock trades at a trailing P/E ratio of 65.8x. Average trailing P/E is 50x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 26%After last week's 26% share price gain to CN¥23.55, the stock trades at a trailing P/E ratio of 57.8x. Average trailing P/E is 52x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.お知らせ • Dec 26Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026New Risk • Dec 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥18.15, the stock trades at a trailing P/E ratio of 44.6x. Average trailing P/E is 42x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years.Valuation Update With 7 Day Price Move • Nov 24Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥15.93, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 41x in the Chemicals industry in China. Total loss to shareholders of 4.5% over the past three years.Reported Earnings • Oct 26Third quarter 2025 earnings released: EPS: CN¥0.081 (vs CN¥0.099 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.081 (down from CN¥0.099 in 3Q 2024). Revenue: CN¥528.5m (down 7.1% from 3Q 2024). Net income: CN¥28.9m (down 15% from 3Q 2024). Profit margin: 5.5% (down from 6.0% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2025 Results on Oct 25, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025Reported Earnings • Aug 25Second quarter 2025 earnings released: EPS: CN¥0.14 (vs CN¥0.048 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.048 in 2Q 2024). Revenue: CN¥548.2m (flat on 2Q 2024). Net income: CN¥49.1m (up 185% from 2Q 2024). Profit margin: 9.0% (up from 3.1% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.お知らせ • Jun 30Guizhou RedStar Developing Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025New Risk • Jun 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.0% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥16.08, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 36x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.Declared Dividend • Jun 07Dividend increased to CN¥0.02Dividend of CN¥0.02 is 100% higher than last year. Ex-date: 13th June 2025 Payment date: 13th June 2025 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.4% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 15% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Apr 28First quarter 2025 earnings released: EPS: CN¥0.09 (vs CN¥0.02 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.09 (up from CN¥0.02 in 1Q 2024). Revenue: CN¥532.7m (up 8.1% from 1Q 2024). Net income: CN¥29.3m (up 363% from 1Q 2024). Profit margin: 5.5% (up from 1.3% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.New Risk • Apr 27New major risk - Revenue and earnings growthEarnings have declined by 4.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.6% per year over the past 5 years. Minor Risk Large one-off items impacting financial results.お知らせ • Apr 26Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 23, 2025Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 23, 2025, at 14:30 China Standard Time. Location: 4F, No. 8, Jiyang Road, Shibei District, Qingdao, Shandong ChinaValuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥12.05, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 49% over the past three years.お知らせ • Mar 28Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025Valuation Update With 7 Day Price Move • Mar 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥15.26, the stock trades at a trailing P/E ratio of 79.6x. Average trailing P/E is 37x in the Chemicals industry in China. Total loss to shareholders of 26% over the past three years.New Risk • Jan 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥14.47, the stock trades at a trailing P/E ratio of 75.5x. Average trailing P/E is 34x in the Chemicals industry in China. Total loss to shareholders of 3.5% over the past three years.お知らせ • Dec 27Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025分析記事 • Nov 22Guizhou RedStar Developing Co.,Ltd.'s (SHSE:600367) 32% Price Boost Is Out Of Tune With RevenuesDespite an already strong run, Guizhou RedStar Developing Co.,Ltd. ( SHSE:600367 ) shares have been powering on, with a...Valuation Update With 7 Day Price Move • Nov 22Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥14.52, the stock trades at a trailing P/E ratio of 75.8x. Average trailing P/E is 36x in the Chemicals industry in China. Total loss to shareholders of 9.7% over the past three years.分析記事 • Oct 28Guizhou RedStar DevelopingLtd's (SHSE:600367) Earnings Might Be Weaker Than You ThinkShareholders were pleased with the recent earnings report from Guizhou RedStar Developing Co.,Ltd. ( SHSE:600367...Reported Earnings • Oct 22Third quarter 2024 earnings released: EPS: CN¥0.099 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.099. Revenue: CN¥569.1m (up 3.7% from 3Q 2023). Net income: CN¥33.9m (up 133% from 3Q 2023). Profit margin: 6.0% (up from 2.7% in 3Q 2023).お知らせ • Sep 30Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024Upcoming Dividend • Sep 23Upcoming dividend of CN¥0.01 per shareEligible shareholders must have bought the stock before 30 September 2024. Payment date: 30 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of Chinese dividend payers (2.8%). Lower than average of industry peers (2.2%).New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Shareholders have been diluted in the past year (16% increase in shares outstanding).Buy Or Sell Opportunity • Jul 26Now 23% overvaluedOver the last 90 days, the stock has fallen 13% to CN¥9.60. The fair value is estimated to be CN¥7.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 39%.お知らせ • Jun 28Guizhou RedStar Developing Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report first half, 2024 results on Aug 28, 2024分析記事 • May 21There's Reason For Concern Over Guizhou RedStar Developing Co.,Ltd.'s (SHSE:600367) Massive 25% Price JumpGuizhou RedStar Developing Co.,Ltd. ( SHSE:600367 ) shares have continued their recent momentum with a 25% gain in the...お知らせ • Apr 27Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 22, 2024Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 22, 2024, at 14:30 China Standard Time. Location: 4F, No. 8, Jiyang Road, Shibei District, Qingdao, Shandong ChinaReported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.02 loss in 1Q 2023)First quarter 2024 results: EPS: CN¥0.02 (up from CN¥0.02 loss in 1Q 2023). Revenue: CN¥492.6m (up 2.6% from 1Q 2023). Net income: CN¥6.34m (up CN¥12.8m from 1Q 2023). Profit margin: 1.3% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.お知らせ • Mar 30Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024お知らせ • Dec 29Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024New Risk • Dec 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Shareholders have been diluted in the past year (16% increase in shares outstanding).Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.091 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11. Revenue: CN¥548.9m (down 14% from 3Q 2022). Net income: CN¥14.6m (down 45% from 3Q 2022). Profit margin: 2.7% (down from 4.1% in 3Q 2022). The decrease in margin was driven by lower revenue.Buying Opportunity • Oct 11Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥16.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 35%.Buying Opportunity • Sep 26Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥16.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 35%.New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).Reported Earnings • Aug 28Second quarter 2023 earnings released: EPS: CN¥0.022 (vs CN¥0.38 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.022 (down from CN¥0.38 in 2Q 2022). Revenue: CN¥539.0m (down 12% from 2Q 2022). Net income: CN¥10.4m (down 91% from 2Q 2022). Profit margin: 1.9% (down from 18% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥15.87, the stock trades at a trailing P/E ratio of 39.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 118% over the past three years.New Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Profit margins are more than 30% lower than last year (4.5% net profit margin).Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥14.64, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years.Reported Earnings • Apr 22Full year 2022 earnings released: EPS: CN¥0.74 (vs CN¥0.90 in FY 2021)Full year 2022 results: EPS: CN¥0.74 (down from CN¥0.90 in FY 2021). Revenue: CN¥2.85b (up 30% from FY 2021). Net income: CN¥214.9m (down 18% from FY 2021). Profit margin: 7.5% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Dec 19Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 78%.Buying Opportunity • Nov 18Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 29%. The fair value is estimated to be CN¥22.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 78%.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Yongmei Zhang was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Nov 02Guizhou RedStar Developing Co.,Ltd. announced that it expects to receive CNY 580 million in funding from Qingdao Redstar Chemical Group Company Ltd. and other investorsGuizhou RedStar Developing Co.,Ltd. announced that it has entered into share subscription agreement not more than 87,970,980 A shares pre-plan at an issue price for an aggregate gross proceeds of not more than CNY 580,000,000 on October 31, 2022. The company shall issue shares at a price not less than 80% of the average price in the 20 trading days before the pricing reference date. The transaction will include participation from not more than 35, including Qingdao Redstar Chemical Group Company Ltd. The shares to be issued shall have a hold period of 18 months and 6 months for Qingdao Redstar Chemical Group Company Ltd and other investors respectively. The transaction has been approved at the 10th meeting of the 8th supervisory board of the company. The transaction is still subject to the approvals of the company’s shareholders, the State-owned Assets Supervision and Administration, and the China Securities Regulatory Commission.お知らせ • Oct 29Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) signed an agreement to acquire 75% stake in Qingdao Red Butterfly Precision Materials Co., Ltd. from Qingdao Redstar Chemical Group Company Ltd. for CNY 405 million.Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) signed an agreement to acquire 75% stake in Qingdao Red Butterfly Precision Materials Co., Ltd. from Qingdao Redstar Chemical Group Company Ltd. for CNY 405 million on October 27, 2022. As per the terms of agreement, Guizhou RedStar Developing will pay first installment of CNY 300 million within five working days from the date of signing the agreement and second installment of CNY 106.96428 will pay within one year from signing the agreement.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.091 (vs CN¥0.24 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.091 (down from CN¥0.24 in 3Q 2021). Revenue: CN¥640.0m (up 18% from 3Q 2021). Net income: CN¥26.4m (down 62% from 3Q 2021). Profit margin: 4.1% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 12Second quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.18 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.38 (up from CN¥0.18 in 2Q 2021). Revenue: CN¥610.7m (up 15% from 2Q 2021). Net income: CN¥110.6m (up 101% from 2Q 2021). Profit margin: 18% (up from 10% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥26.85, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 261% over the past three years.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.29, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 222% over the past three years.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥23.03, the stock trades at a trailing P/E ratio of 20.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 164% over the past three years.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (7 non-independent directors). Director Yang Wan was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥26.50, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 207% over the past three years.Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.36, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 154% over the past three years.Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥18.97, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 164% over the past three years.Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥18.94, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 142% over the past three years.Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.042 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥544.5m (up 66% from 3Q 2020). Net income: CN¥68.7m (up CN¥75.9m from 3Q 2020). Profit margin: 13% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥17.78, the stock trades at a trailing P/E ratio of 40.3x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years.Valuation Update With 7 Day Price Move • Sep 10Investor sentiment improved over the past weekAfter last week's 38% share price gain to CN¥21.46, the stock trades at a trailing P/E ratio of 45.3x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 166% over the past three years.Valuation Update With 7 Day Price Move • Aug 27Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥17.09, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 105% over the past three years.Reported Earnings • Aug 15Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.011 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥529.9m (up 65% from 2Q 2020). Net income: CN¥55.1m (up CN¥51.1m from 2Q 2020). Profit margin: 10% (up from 1.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥14.86, the stock trades at a trailing P/E ratio of 54.7x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 74% over the past three years.Valuation Update With 7 Day Price Move • Jul 23Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥11.97, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥9.81, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 17% over the past three years.Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥9.20, the stock trades at a trailing P/E ratio of 33.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 8.1% over the past three years.Reported Earnings • Apr 11Full year 2020 earnings released: EPS CN¥0.19 (vs CN¥0.26 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥1.38b (down 9.6% from FY 2019). Net income: CN¥55.1m (down 26% from FY 2019). Profit margin: 4.0% (down from 4.9% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Feb 25New 90-day high: CN¥8.03The company is up 8.0% from its price of CN¥7.45 on 27 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 17% over the same period.Is New 90 Day High Low • Feb 04New 90-day low: CN¥6.40The company is down 9.0% from its price of CN¥7.06 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.お知らせ • Jan 31Qingdao Port International Co., Ltd. (SEHK:6198) completed the acquisition of 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) for approximately CNY 120 million.Qingdao Port International Co., Ltd. (SEHK:6198) entered into a share transfer agreement to acquire 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) on April 9, 2020. Qingdao Port International Co., Ltd. also acquired creditor's rights. The equity transfer is for CNY 64.1 million. The consideration will be paid in tranches. Qingdao Red Star Logistics Industry Co. Ltd. reported total assets of CNY 306.4 million and net assets of CNY 30.7 million as of April 30, 2019. The transaction has been approved by the Board of Guizhou RedStar Developing Co.,Ltd. Qingdao Port International Co., Ltd. (SEHK:6198) completed the acquisition of 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) for approximately CNY 120 million on January 29, 2021. Guizhou RedStar Developing Co.,Ltd has received a total of 90% of the equity transfer price of CNY 57.6 million and 90% of the creditor’s rights transfer price of CNY 48.3 million. The remaining 10% of the equity transfer price and creditor's rights transfer price will be paid within 10 working days from the date when Qingdao Red Star Logistics Industry Co. Ltd completes the real estate certificate procedures.Is New 90 Day High Low • Jan 13New 90-day low: CN¥6.61The company is down 8.0% from its price of CN¥7.22 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Dec 10New 90-day high: CN¥7.74The company is up 6.0% from its price of CN¥7.31 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Oct 31New 90-day low: CN¥6.89The company is down 11% from its price of CN¥7.76 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.Reported Earnings • Oct 17Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.85m, down 96% from the prior year. Total revenue was CN¥1.28b over the last 12 months, down 20% from the prior year.お知らせ • Oct 15Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2020 Results on Oct 17, 2020Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2020 results on Oct 17, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Guizhou RedStar DevelopingLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測SHSE:600367 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20262,07592-42173N/A12/31/20252,13593-37186N/A9/30/20252,19513973319N/A6/30/20252,23614454301N/A3/31/20252,237112-57169N/A12/31/20242,1978931205N/A9/30/20242,2416554179N/A6/30/20242,2204684173N/A3/31/20242,21039181246N/A12/31/20232,19726122204N/A9/30/20232,333-557215N/A6/30/20232,49512139293N/A3/31/20232,641118130282N/A12/31/20222,853215160284N/A9/30/20223,173395217281N/A6/30/20223,007433211274N/A3/31/20222,852372221288N/A12/31/20212,540294181255N/A9/30/20211,934205120172N/A6/30/20211,71913067122N/A3/31/20211,50978-258N/A12/31/20201,37855-3230N/A9/30/20201,2783-98-33N/A6/30/20201,33825-138-66N/A3/31/20201,39348-162-98N/A12/31/20191,52375N/A55N/A9/30/20191,58874N/A103N/A6/30/20191,62393N/A173N/A3/31/20191,627111N/A242N/A12/31/20181,593116N/A91N/A9/30/20181,489120N/A81N/A6/30/20181,418122N/A80N/A3/31/20181,362103N/A67N/A12/31/20171,33595N/A131N/A9/30/20171,32592N/A136N/A6/30/20171,27556N/A89N/A3/31/20171,26157N/A122N/A12/31/20161,17246N/A118N/A9/30/20161,107-152N/A163N/A6/30/20161,075-152N/A164N/A3/31/20161,051-182N/A103N/A12/31/20151,043-190N/A115N/A9/30/20151,0679N/A58N/A6/30/20151,09019N/A8N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 600367の予測収益成長が 貯蓄率 ( 2.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 600367の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 600367の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 600367の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 600367の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 600367の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/15 21:16終値2026/05/15 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Guizhou RedStar Developing Co.,Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Apr 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 25% per year over the past 5 years. Minor Risk Large one-off items impacting financial results.
Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.08 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.08 (down from CN¥0.09 in 1Q 2025). Revenue: CN¥472.9m (down 11% from 1Q 2025). Net income: CN¥28.6m (down 2.3% from 1Q 2025). Profit margin: 6.1% (up from 5.5% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.
お知らせ • Apr 25Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 18, 2026Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Anshun, Guizhou China
お知らせ • Mar 30Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2026 Results on Apr 25, 2026Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2026 results on Apr 25, 2026
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥26.81, the stock trades at a trailing P/E ratio of 65.8x. Average trailing P/E is 50x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 26%After last week's 26% share price gain to CN¥23.55, the stock trades at a trailing P/E ratio of 57.8x. Average trailing P/E is 52x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years.
お知らせ • Dec 26Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026
New Risk • Dec 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change).
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥18.15, the stock trades at a trailing P/E ratio of 44.6x. Average trailing P/E is 42x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years.
Valuation Update With 7 Day Price Move • Nov 24Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥15.93, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 41x in the Chemicals industry in China. Total loss to shareholders of 4.5% over the past three years.
Reported Earnings • Oct 26Third quarter 2025 earnings released: EPS: CN¥0.081 (vs CN¥0.099 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.081 (down from CN¥0.099 in 3Q 2024). Revenue: CN¥528.5m (down 7.1% from 3Q 2024). Net income: CN¥28.9m (down 15% from 3Q 2024). Profit margin: 5.5% (down from 6.0% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2025 Results on Oct 25, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025
Reported Earnings • Aug 25Second quarter 2025 earnings released: EPS: CN¥0.14 (vs CN¥0.048 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.048 in 2Q 2024). Revenue: CN¥548.2m (flat on 2Q 2024). Net income: CN¥49.1m (up 185% from 2Q 2024). Profit margin: 9.0% (up from 3.1% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.
お知らせ • Jun 30Guizhou RedStar Developing Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025
New Risk • Jun 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.0% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
Valuation Update With 7 Day Price Move • Jun 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥16.08, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 36x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.
Declared Dividend • Jun 07Dividend increased to CN¥0.02Dividend of CN¥0.02 is 100% higher than last year. Ex-date: 13th June 2025 Payment date: 13th June 2025 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.4% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 15% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Apr 28First quarter 2025 earnings released: EPS: CN¥0.09 (vs CN¥0.02 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.09 (up from CN¥0.02 in 1Q 2024). Revenue: CN¥532.7m (up 8.1% from 1Q 2024). Net income: CN¥29.3m (up 363% from 1Q 2024). Profit margin: 5.5% (up from 1.3% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
New Risk • Apr 27New major risk - Revenue and earnings growthEarnings have declined by 4.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.6% per year over the past 5 years. Minor Risk Large one-off items impacting financial results.
お知らせ • Apr 26Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 23, 2025Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 23, 2025, at 14:30 China Standard Time. Location: 4F, No. 8, Jiyang Road, Shibei District, Qingdao, Shandong China
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥12.05, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 49% over the past three years.
お知らせ • Mar 28Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥15.26, the stock trades at a trailing P/E ratio of 79.6x. Average trailing P/E is 37x in the Chemicals industry in China. Total loss to shareholders of 26% over the past three years.
New Risk • Jan 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥14.47, the stock trades at a trailing P/E ratio of 75.5x. Average trailing P/E is 34x in the Chemicals industry in China. Total loss to shareholders of 3.5% over the past three years.
お知らせ • Dec 27Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025
分析記事 • Nov 22Guizhou RedStar Developing Co.,Ltd.'s (SHSE:600367) 32% Price Boost Is Out Of Tune With RevenuesDespite an already strong run, Guizhou RedStar Developing Co.,Ltd. ( SHSE:600367 ) shares have been powering on, with a...
Valuation Update With 7 Day Price Move • Nov 22Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥14.52, the stock trades at a trailing P/E ratio of 75.8x. Average trailing P/E is 36x in the Chemicals industry in China. Total loss to shareholders of 9.7% over the past three years.
分析記事 • Oct 28Guizhou RedStar DevelopingLtd's (SHSE:600367) Earnings Might Be Weaker Than You ThinkShareholders were pleased with the recent earnings report from Guizhou RedStar Developing Co.,Ltd. ( SHSE:600367...
Reported Earnings • Oct 22Third quarter 2024 earnings released: EPS: CN¥0.099 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.099. Revenue: CN¥569.1m (up 3.7% from 3Q 2023). Net income: CN¥33.9m (up 133% from 3Q 2023). Profit margin: 6.0% (up from 2.7% in 3Q 2023).
お知らせ • Sep 30Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024
Upcoming Dividend • Sep 23Upcoming dividend of CN¥0.01 per shareEligible shareholders must have bought the stock before 30 September 2024. Payment date: 30 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of Chinese dividend payers (2.8%). Lower than average of industry peers (2.2%).
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Shareholders have been diluted in the past year (16% increase in shares outstanding).
Buy Or Sell Opportunity • Jul 26Now 23% overvaluedOver the last 90 days, the stock has fallen 13% to CN¥9.60. The fair value is estimated to be CN¥7.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 39%.
お知らせ • Jun 28Guizhou RedStar Developing Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report first half, 2024 results on Aug 28, 2024
分析記事 • May 21There's Reason For Concern Over Guizhou RedStar Developing Co.,Ltd.'s (SHSE:600367) Massive 25% Price JumpGuizhou RedStar Developing Co.,Ltd. ( SHSE:600367 ) shares have continued their recent momentum with a 25% gain in the...
お知らせ • Apr 27Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 22, 2024Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 22, 2024, at 14:30 China Standard Time. Location: 4F, No. 8, Jiyang Road, Shibei District, Qingdao, Shandong China
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.02 loss in 1Q 2023)First quarter 2024 results: EPS: CN¥0.02 (up from CN¥0.02 loss in 1Q 2023). Revenue: CN¥492.6m (up 2.6% from 1Q 2023). Net income: CN¥6.34m (up CN¥12.8m from 1Q 2023). Profit margin: 1.3% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
お知らせ • Mar 30Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
お知らせ • Dec 29Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024
New Risk • Dec 03New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Shareholders have been diluted in the past year (16% increase in shares outstanding).
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.091 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11. Revenue: CN¥548.9m (down 14% from 3Q 2022). Net income: CN¥14.6m (down 45% from 3Q 2022). Profit margin: 2.7% (down from 4.1% in 3Q 2022). The decrease in margin was driven by lower revenue.
Buying Opportunity • Oct 11Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥16.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 35%.
Buying Opportunity • Sep 26Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥16.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 35%.
New Risk • Aug 28New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).
Reported Earnings • Aug 28Second quarter 2023 earnings released: EPS: CN¥0.022 (vs CN¥0.38 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.022 (down from CN¥0.38 in 2Q 2022). Revenue: CN¥539.0m (down 12% from 2Q 2022). Net income: CN¥10.4m (down 91% from 2Q 2022). Profit margin: 1.9% (down from 18% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥15.87, the stock trades at a trailing P/E ratio of 39.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 118% over the past three years.
New Risk • Jun 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Profit margins are more than 30% lower than last year (4.5% net profit margin).
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥14.64, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years.
Reported Earnings • Apr 22Full year 2022 earnings released: EPS: CN¥0.74 (vs CN¥0.90 in FY 2021)Full year 2022 results: EPS: CN¥0.74 (down from CN¥0.90 in FY 2021). Revenue: CN¥2.85b (up 30% from FY 2021). Net income: CN¥214.9m (down 18% from FY 2021). Profit margin: 7.5% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Dec 19Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 78%.
Buying Opportunity • Nov 18Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 29%. The fair value is estimated to be CN¥22.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 78%.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Yongmei Zhang was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 02Guizhou RedStar Developing Co.,Ltd. announced that it expects to receive CNY 580 million in funding from Qingdao Redstar Chemical Group Company Ltd. and other investorsGuizhou RedStar Developing Co.,Ltd. announced that it has entered into share subscription agreement not more than 87,970,980 A shares pre-plan at an issue price for an aggregate gross proceeds of not more than CNY 580,000,000 on October 31, 2022. The company shall issue shares at a price not less than 80% of the average price in the 20 trading days before the pricing reference date. The transaction will include participation from not more than 35, including Qingdao Redstar Chemical Group Company Ltd. The shares to be issued shall have a hold period of 18 months and 6 months for Qingdao Redstar Chemical Group Company Ltd and other investors respectively. The transaction has been approved at the 10th meeting of the 8th supervisory board of the company. The transaction is still subject to the approvals of the company’s shareholders, the State-owned Assets Supervision and Administration, and the China Securities Regulatory Commission.
お知らせ • Oct 29Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) signed an agreement to acquire 75% stake in Qingdao Red Butterfly Precision Materials Co., Ltd. from Qingdao Redstar Chemical Group Company Ltd. for CNY 405 million.Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) signed an agreement to acquire 75% stake in Qingdao Red Butterfly Precision Materials Co., Ltd. from Qingdao Redstar Chemical Group Company Ltd. for CNY 405 million on October 27, 2022. As per the terms of agreement, Guizhou RedStar Developing will pay first installment of CNY 300 million within five working days from the date of signing the agreement and second installment of CNY 106.96428 will pay within one year from signing the agreement.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.091 (vs CN¥0.24 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.091 (down from CN¥0.24 in 3Q 2021). Revenue: CN¥640.0m (up 18% from 3Q 2021). Net income: CN¥26.4m (down 62% from 3Q 2021). Profit margin: 4.1% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 12Second quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.18 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.38 (up from CN¥0.18 in 2Q 2021). Revenue: CN¥610.7m (up 15% from 2Q 2021). Net income: CN¥110.6m (up 101% from 2Q 2021). Profit margin: 18% (up from 10% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 09Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥26.85, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 261% over the past three years.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.29, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 222% over the past three years.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥23.03, the stock trades at a trailing P/E ratio of 20.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 164% over the past three years.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (7 non-independent directors). Director Yang Wan was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥26.50, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 207% over the past three years.
Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.36, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 154% over the past three years.
Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥18.97, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 164% over the past three years.
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥18.94, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 142% over the past three years.
Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.042 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥544.5m (up 66% from 3Q 2020). Net income: CN¥68.7m (up CN¥75.9m from 3Q 2020). Profit margin: 13% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥17.78, the stock trades at a trailing P/E ratio of 40.3x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years.
Valuation Update With 7 Day Price Move • Sep 10Investor sentiment improved over the past weekAfter last week's 38% share price gain to CN¥21.46, the stock trades at a trailing P/E ratio of 45.3x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 166% over the past three years.
Valuation Update With 7 Day Price Move • Aug 27Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥17.09, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 105% over the past three years.
Reported Earnings • Aug 15Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.011 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥529.9m (up 65% from 2Q 2020). Net income: CN¥55.1m (up CN¥51.1m from 2Q 2020). Profit margin: 10% (up from 1.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥14.86, the stock trades at a trailing P/E ratio of 54.7x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 74% over the past three years.
Valuation Update With 7 Day Price Move • Jul 23Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥11.97, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.
Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥9.81, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 17% over the past three years.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥9.20, the stock trades at a trailing P/E ratio of 33.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 8.1% over the past three years.
Reported Earnings • Apr 11Full year 2020 earnings released: EPS CN¥0.19 (vs CN¥0.26 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥1.38b (down 9.6% from FY 2019). Net income: CN¥55.1m (down 26% from FY 2019). Profit margin: 4.0% (down from 4.9% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Feb 25New 90-day high: CN¥8.03The company is up 8.0% from its price of CN¥7.45 on 27 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 17% over the same period.
Is New 90 Day High Low • Feb 04New 90-day low: CN¥6.40The company is down 9.0% from its price of CN¥7.06 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.
お知らせ • Jan 31Qingdao Port International Co., Ltd. (SEHK:6198) completed the acquisition of 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) for approximately CNY 120 million.Qingdao Port International Co., Ltd. (SEHK:6198) entered into a share transfer agreement to acquire 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) on April 9, 2020. Qingdao Port International Co., Ltd. also acquired creditor's rights. The equity transfer is for CNY 64.1 million. The consideration will be paid in tranches. Qingdao Red Star Logistics Industry Co. Ltd. reported total assets of CNY 306.4 million and net assets of CNY 30.7 million as of April 30, 2019. The transaction has been approved by the Board of Guizhou RedStar Developing Co.,Ltd. Qingdao Port International Co., Ltd. (SEHK:6198) completed the acquisition of 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) for approximately CNY 120 million on January 29, 2021. Guizhou RedStar Developing Co.,Ltd has received a total of 90% of the equity transfer price of CNY 57.6 million and 90% of the creditor’s rights transfer price of CNY 48.3 million. The remaining 10% of the equity transfer price and creditor's rights transfer price will be paid within 10 working days from the date when Qingdao Red Star Logistics Industry Co. Ltd completes the real estate certificate procedures.
Is New 90 Day High Low • Jan 13New 90-day low: CN¥6.61The company is down 8.0% from its price of CN¥7.22 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Dec 10New 90-day high: CN¥7.74The company is up 6.0% from its price of CN¥7.31 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Oct 31New 90-day low: CN¥6.89The company is down 11% from its price of CN¥7.76 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.
Reported Earnings • Oct 17Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥2.85m, down 96% from the prior year. Total revenue was CN¥1.28b over the last 12 months, down 20% from the prior year.
お知らせ • Oct 15Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2020 Results on Oct 17, 2020Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2020 results on Oct 17, 2020